Pharmaceuticals

Drug Development Drug Safety Weight Loss Drugs Weight Loss Clinical Trials Drug Pricing Drug Regulation Medications Drug Approval Drug Manufacturing

Law Firms Urge Telix Investors as Jan. 9 Lead-Plaintiff Deadline Nears

The filing cites regulatory disclosures that investors say drove sharp Telix losses.

Hagens Berman and Pomerantz Launch Probes Into Rezolute After Phase 3 Ersodetug Failure

FDA Issues Complete Response Letter for Corcept’s Relacorilant Hypertension Bid

RFK Jr. Overhauls HHS With Deep Cuts, MAHA Push and Vaccine Policy Reversals

Skye Bioscience Faces Investor Class Actions as Firms Court Shareholders Before Jan. 16 Deadline

Law Firms Urge Telix Investors Ahead of Lead‑Plaintiff Deadline in Securities Class Action

Cell Study Finds ADHD Stimulants Boost Wakefulness and Reward Systems, Not Attention Circuits

FDA Clears Wegovy Pill, Handing Novo Nordisk a Short-Term Edge in Obesity-Drug Race

RMIT Engineers Nanodots That Kill Cancer Cells in Lab Tests While Largely Sparing Healthy Cells

Nvidia Reportedly Pauses Intel 18A Chip Tests, Knocking Intel Shares

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

AstraZeneca Withdraws Andexxa From U.S. Market After FDA Says Risks Outweigh Benefits

White House Secures Nine More Drugmaker Pacts on MFN Pricing as TrumpRx Nears Launch

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections

FDA Clears First New Oral Gonorrhea Antibiotics in Over 30 Years

Chai Discovery Raises $130 Million Series B at $1.3 Billion Valuation

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65

Nektar’s Alopecia Drug Misses Phase 2b Goal as Company Cites Ineligible Patients, Plans Phase 3